Head and neck cancers are the sixth most common cancers worldwide, in large part due to the presence of the HPV virus.
Today in Healthy Living Michelle Dunaway shows us the immunotherapy treatment they say is highly effective for patients with cancer that spreads or comes back.
Doctors say the survival rates for patients who continued on Nivolumab were twice of those who did not take the immunotherapy drug, and 20 percent of the patients on the drug had their tumors shrink.
© 2023 - 910 Media Group